微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -1.43% | -750% | 5.92% | 63/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | -1.52% | -143.68% | -376.36% | 53/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 0.55% | -73.56% | -32.93% | 56/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 0.82% | -36.43% | 272.73% | 52/69 | 0.67% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 0.22% | -31.25% | -93.68% | 59/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 3.48% | -10.08% | 67.31% | 46/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 2.08% | -22.39% | 61.24% | 56/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 1.29% | -21.82% | 303.13% | 55/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 0.32% | -63.64% | -91.73% | 59/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 3.87% | -48.05% | 44.4% | 44/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 2.68% | -25.14% | 62.42% | 53/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 1.65% | -52.86% | 87.5% | 53/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 0.88% | -31.25% | -88.19% | 53/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 7.45% | 43.55% | 108.1% | 34/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 3.58% | 4.07% | 2.29% | 54/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 3.5% | 21.53% | 173.44% | 43/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 1.28% | 75.34% | -75.34% | 53/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 5.19% | -25.86% | 50.87% | 42/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 3.44% | -44.07% | 19.44% | 51/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 2.88% | -32.87% | 294.52% | 41/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 0.73% | -50% | -89.57% | 54/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 7% | 105.88% | 13.82% | 39/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 6.15% | 228.88% | 43.36% | 40/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 4.29% | 366.3% | 193.84% | 37/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 1.46% | 48.98% | -57.06% | 49/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 3.4% | 109.88% | 81.82% | 53/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 1.87% | 122.86% | 103.26% | 58/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 0.92% | -66.55% | -6.12% | 59/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 0.98% | 88.46% | -39.51% | 51/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 1.62% | -72.12% | 119.8% | 62/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | -8.18% | -342.01% | -397.45% | 62/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 2.75% | -1.79% | 428.85% | 50/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 0.52% | -48% | -91.05% | 56/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 5.81% | 172.63% | 71.89% | 49/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 3.38% | 134.14% | 20.71% | 49/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 2.8% | 428.3% | 180% | 48/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 1% | 51.52% | 112.5% | 45/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | -8% | -579.04% | 19.19% | 62/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | -9.9% | -456.12% | -1967.93% | 53/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 0.53% | -77.06% | -19.7% | 52/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 0.66% | -38.32% | -60.48% | 48/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |